Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUININE | 200MG | CAPSULE | Resolved | 2017-12-14 | 2018-04-17 | 32809 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2018-07-04 | 2018-07-17 | 54309 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2017-07-11 | 2017-07-27 | 15375 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2017-03-11 | 2017-05-23 | 466 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Resolved | 2017-04-11 | 2017-05-25 | 6516 |
| APO-RALOXIFENE | 60MG | TABLET | Resolved | 2020-06-24 | 2020-11-02 | 118772 |
| APO-RALOXIFENE | 60MG | TABLET | Resolved | 2023-01-13 | 2023-04-21 | 181104 |
| APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-05-13 | 2020-05-25 | 114955 |
| APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-05-20 | 2020-05-25 | 115404 |
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-09-27 | 2017-12-14 | 23641 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-09-27 | 2017-11-09 | 23644 |
| APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2017-11-28 | 2018-03-08 | 30957 |
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-11-28 | 2018-02-21 | 31028 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-03-12 | 2017-03-16 | 731 |
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-03-12 | 2017-03-16 | 734 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-04-07 | 2017-06-09 | 6000 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-05-02 | 2017-06-09 | 8705 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-05-02 | 2017-06-08 | 8707 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2019-01-03 | 2019-01-17 | 71148 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2019-02-06 | 2019-03-07 | 74932 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |